Joel M. Guthridge

13.1k total citations
125 papers, 4.6k citations indexed

About

Joel M. Guthridge is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joel M. Guthridge has authored 125 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Immunology, 71 papers in Rheumatology and 31 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joel M. Guthridge's work include Systemic Lupus Erythematosus Research (69 papers), T-cell and B-cell Immunology (34 papers) and Monoclonal and Polyclonal Antibodies Research (31 papers). Joel M. Guthridge is often cited by papers focused on Systemic Lupus Erythematosus Research (69 papers), T-cell and B-cell Immunology (34 papers) and Monoclonal and Polyclonal Antibodies Research (31 papers). Joel M. Guthridge collaborates with scholars based in United States, United Kingdom and Canada. Joel M. Guthridge's co-authors include Judith A. James, V. Michael Holers, John B. Harley, Melissa E. Munroe, Joan T. Merrill, Rufei Lu, Hector Molina, Jennifer A. Kelly, Kendra A. Young and Timothy B. Niewold and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Joel M. Guthridge

122 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel M. Guthridge United States	38	2.6k	2.2k	737	671	643	125	4.6k
Christopher Sjöwall Sweden	38	2.1k 0.8×	2.2k 1.0×	612 0.8×	719 1.1×	339 0.5×	175	3.8k
Jennifer H. Anolik United States	41	3.7k 1.4×	2.5k 1.1×	944 1.3×	1.5k 2.3×	630 1.0×	89	6.1k
Kenneth M. Kaufman United States	32	2.2k 0.8×	1.8k 0.8×	806 1.1×	524 0.8×	395 0.6×	87	4.0k
Thierry Martin France	33	2.2k 0.8×	1.3k 0.6×	1.3k 1.7×	785 1.2×	602 0.9×	152	5.2k
Jacques‐Olivier Pers France	46	2.5k 0.9×	1.4k 0.7×	847 1.1×	586 0.9×	711 1.1×	181	6.5k
Blaž Rozman Slovenia	36	1.5k 0.6×	3.4k 1.5×	955 1.3×	685 1.0×	578 0.9×	119	5.8k
Boris Gilburd Israel	39	2.2k 0.9×	2.2k 1.0×	857 1.2×	796 1.2×	424 0.7×	146	4.5k
Robert W. Hoffman United States	34	2.0k 0.8×	1.7k 0.8×	496 0.7×	896 1.3×	654 1.0×	92	3.8k
Eugen Feist Germany	39	2.3k 0.9×	2.5k 1.1×	1.5k 2.0×	788 1.2×	407 0.6×	202	5.7k
Timothy R. D. J. Radstake Netherlands	34	2.5k 1.0×	1.3k 0.6×	960 1.3×	283 0.4×	750 1.2×	81	4.5k

Countries citing papers authored by Joel M. Guthridge

Since Specialization

Citations

This map shows the geographic impact of Joel M. Guthridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel M. Guthridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel M. Guthridge more than expected).

Fields of papers citing papers by Joel M. Guthridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel M. Guthridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel M. Guthridge. The network helps show where Joel M. Guthridge may publish in the future.

Co-authorship network of co-authors of Joel M. Guthridge

This figure shows the co-authorship network connecting the top 25 collaborators of Joel M. Guthridge. A scholar is included among the top collaborators of Joel M. Guthridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel M. Guthridge. Joel M. Guthridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munroe, Melissa E., Kendra A. Young, Rufei Lu, et al.. (2025). Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Science & Medicine. 12(2). e001753–e001753. 1 indexed citations

Olsen, Nancy J., Duanping Liao, Judith A. James, et al.. (2025). A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus. Arthritis & Rheumatology.

Siebert, Nadja, Klemens Ruprecht, Gaurav Kumar, et al.. (2024). Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion. Neurology Neuroimmunology & Neuroinflammation. 11(4). e200268–e200268. 1 indexed citations

Smith, Miles, Kirk R. Thomas, Carla Guthridge, et al.. (2023). OP0109 SINGLE-CELL RNA-SEQ REVEALS DIFFERENCES IN METABOLIC PATHWAYS OF MYELOID CELLS IN THE PROGRESSION OF SLE. Annals of the Rheumatic Diseases. 82. 72–73. 1 indexed citations

Smith, Miles, Kevin L. Thomas, Susan Macwana, et al.. (2023). POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS. Annals of the Rheumatic Diseases. 82. 909–909. 1 indexed citations

Marlin, M. Caleb, et al.. (2023). A novel process for H&E, immunofluorescence, and imaging mass cytometry on a single slide with a concise analytics pipeline. Cytometry Part A. 103(12). 1010–1018. 3 indexed citations

Abadie, Roberto, M. Caleb Marlin, Andrew G. Chapple, et al.. (2023). Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection. Journal of Leukocyte Biology. 114(2). 142–153. 2 indexed citations

Marlin, M. Caleb, et al.. (2023). Imaging mass cytometry reveals tissue-specific cellular immune phenotypes in the mouse knee following ACL injury. SHILAP Revista de lepidopterología. 5(4). 100416–100416. 6 indexed citations

Khatri, Bhuwan, Constantin Georgescu, Christina Lawrence, et al.. (2023). Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B. Annals of the Rheumatic Diseases. 82(9). 1181–1190. 10 indexed citations

10.

Singh, Bhupinder, Guru Prasad Maiti, Shu‐Feng Zhou, et al.. (2021). Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis. Arthritis & Rheumatology. 73(12). 2303–2313. 16 indexed citations

11.

Tran, Ly, Miles Smith, Fenping Zheng, et al.. (2021). Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus*. British Journal of Dermatology. 185(3). 563–572. 11 indexed citations

12.

Farris, A. Darise & Joel M. Guthridge. (2020). Overlapping B cell pathways in severe COVID-19 and lupus. Nature Immunology. 21(12). 1478–1480. 9 indexed citations

13.

Ratliff, Michelle, et al.. (2020). TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNα production. Cellular Immunology. 357. 104201–104201. 2 indexed citations

14.

Ghodke‐Puranik, Yogita, Jessica M. Dorschner, Jennifer A. Kelly, et al.. (2019). Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen. Cytokine. 132. 154631–154631. 20 indexed citations

15.

Stathopoulos, Panos, Patrick Waters, Sarosh R. Irani, et al.. (2019). Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity. The Journal of Immunology. 202(8). 2210–2219. 21 indexed citations

16.

Pelikan, Richard, Jennifer A. Kelly, Yao Fu, et al.. (2018). Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks. Nature Communications. 9(1). 2905–2905. 50 indexed citations

17.

Ratliff, Michelle, Mikhail G. Dozmorov, Graham B. Wiley, et al.. (2016). Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels. Data in Brief. 9. 213–219. 10 indexed citations

18.

Bruner, Benjamin F., Joel M. Guthridge, Rufei Lu, et al.. (2012). Comparison of autoantibody specificities between traditional and bead‐based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis & Rheumatism. 64(11). 3677–3686. 70 indexed citations

19.

Fleming, Sherry D., et al.. (2001). Complement Inhibitor, Complement Receptor 1-Related Gene/Protein y-Ig Attenuates Intestinal Damage After the Onset of Mesenteric Ischemia/Reperfusion Injury in Mice. The Journal of Immunology. 167(10). 5921–5927. 66 indexed citations

20.

Guthridge, Joel M., Kendra A. Young, Matthew G. Gipson, et al.. (2001). Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface. The Journal of Immunology. 167(10). 5758–5766. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact